North America Non-Invasive Cardiac Output Monitoring Device Market

Historic Data: 2018-2019   |   Base Year: 2020   |   Forecast Period: 2021-2027

Analysis By Device (Patches, Wristwatches, and Probes & Catheters), Indication (Hypertension, Coronary Diseases, Congenital Problems, Myocardial Ischemia and Infarction, Heart Failure, Arrhythmias, and Others), and End User (Hospitals, Emergency Services Centers, Homecare, and Others)


No. of Pages: 123    |    Report Code: TIPRE00022787    |    Category: Life Sciences

North America Non-Invasive Cardiac Output Monitoring Device Market
Buy Now

Market Introduction

The measurement of cardiac output (CO) is essential in medical practice. In the past, invasive monitoring with a pulmonary artery catheter (PAC) was the gold standard used to measure CO, but in recent years many minimally invasive or non-invasive devices have been developed to measure CO. Cardiac output gives information about tissue perfusion and oxygen delivery and can identify patients who are at high risk of mortality or morbidity.

 


Get more information on this report

North America Non-Invasive Cardiac Output Monitoring Device Strategic Insights

Strategic insights for the North America Non-Invasive Cardiac Output Monitoring Device provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-non-invasive-cardiac-output-monitoring-device-market-strategic-framework.webp
Get more information on this report

North America Non-Invasive Cardiac Output Monitoring Device Report Scope

Report Attribute Details
Market size in 2020 US$ 95,471.09 thousand
Market Size by 2027 US$ 129,912.44 thousand
Global CAGR (2020 - 2027) 5.1%
Historical Data 2018-2019
Forecast period 2021-2027
Segments Covered By Device
  • Patches
  • Wristwatches
  • Probes & Catheters
By Indication
  • Hypertension
  • Coronary Diseases
  • Congenital Problems
  • Myocardial Ischemia and Infarction
  • Heart Failure
  • Arrhythmias
By End User
  • Hospitals
  • Emergency Services Centers
  • Homecare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • General Electric Company
  • Koninklijke Philips N.V.
  • Abbott
  • DELTEX MEDICAL
  • LiDCO
  • CONMED Corporation
  • ImaCor
  • NIMedical
  • Baxter International Inc.
  • Get more information on this report

    North America Non-Invasive Cardiac Output Monitoring Device Regional Insights

    The geographic scope of the North America Non-Invasive Cardiac Output Monitoring Device refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/north-america-non-invasive-cardiac-output-monitoring-device-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The North America non-invasive cardiac output monitoring device market is expected to reach US$ 129,912.44 thousand by 2027 from US$ 95,471.09 thousand in 2020; it is expected to grow at a CAGR of 5.1% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increase in prevalence of cardiovascular diseases and rise in geriatric population. However, the high cost of the device hinders the market growth.

    In recent years, many minimally invasive or non-invasive devices have been developed to measure cardiac output (CO), which is essential in a medical practice. Cardiac output gives information about tissue perfusion and oxygen delivery as well as can identify patients who are at high risk of mortality or morbidity. According to the estimates of the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds due to cardiovascular diseases (CVD) in the US. Thus, the growing prevalence of CVD is boosting the adoption of non-invasive cardiac output monitoring devices. Similarly, geriatric populations are susceptible to many chronic diseases. Most of them suffer from multiple diseases such as diabetes, heart diseases, and pulmonary diseases and some of them undergo surgeries. Non-invasive cardiac output (CO) monitoring is one of the important modern medical practices used while observing critically ill patients. As per the data from World Population Prospects: the 2019 Revision, one in four people in North America would be aged 65 or more by 2050. Moreover, the number of people aged 80 years and above is projected to increase by three-folds from 143 million in 2019 to 426 million by 2050. Thus, increasing geriatric population favours the growth of the market.

     

    Key Market Segments

    Based on device, the North America non-invasive cardiac output monitoring device market is segmented into patches, wristwatches, and probes & catheters. The probes & catheters segment held the largest share of the market in 2019. However, the wristwatches segment is estimated to register the highest CAGR in the market during the forecast period.

    Based on indication, the North America non-invasive cardiac output monitoring device market is segmented into hypertension, coronary diseases, congenital problems, myocardial ischemia and infarction, heart failure, arrhythmias, and others. The hypertension segment held the largest share of the market in 2019. However, the heart failure segment is estimated to register the highest CAGR in the market during the forecast period.

    Based on end user, the North America non-invasive cardiac output monitoring device market is segmented into hospitals, emergency services centers, homecare, and others. The hospitals segment held the largest share of the market in 2019. However, the emergency services centers segment is estimated to register the highest CAGR in the market during the forecast period.

     

    Major Sources and Companies Listed

    Some of the primary and secondary sources associated with this report on the North America non-invasive cardiac output monitoring device market are the U.S Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and American Heart Association (AHA).

     

    Reasons to buy the report

    • Determine prospective investment areas based on a detailed trend analysis of North America non-invasive cardiac output monitoring device market over the next years.
    • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
    • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
    • Identify the major channels driving the North America non-invasive cardiac output monitoring device market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
    • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America non-invasive cardiac output monitoring device market.

     

    NORTH AMERICA NON-INVASIVE CARDIAC OUTPUT MONITORING DEVICE MARKET SEGMENTATION

    By Device

    • Patches
    • Wristwatches
    • Probes & Catheters

    By Indication

    • Hypertension
    • Coronary Diseases
    • Congenital Problems
    • Myocardial Ischemia and Infarction
    • Heart Failure
    • Arrhythmias
    • Others

    By End User

    • Hospitals
    • Emergency Services Centers
    • Homecare
    • Others

    By Country

    • US
    • Canada
    • Mexico

    Company Profiles

    • General Electric Company
    • Koninklijke Philips N.V.
    • Abbott
    • DELTEX MEDICAL
    • LiDCO
    • CONMED Corporation
    • ImaCor
    • NIMedical
    • Baxter International Inc.
     

    The List of Companies - North America Non-Invasive Cardiac Output Monitoring Device Market

    1. General Electric Company
    2. Koninklijke Philips N.V.
    3. Abbott
    4. DELTEX MEDICAL
    5. LiDCO
    6. CONMED Corporation
    7. ImaCor
    8. NIMedical
    9. Baxter International Inc.
    Frequently Asked Questions
    How big is the North America Non-Invasive Cardiac Output Monitoring Device Market?

    The North America Non-Invasive Cardiac Output Monitoring Device Market is valued at US$ 95,471.09 thousand in 2020, it is projected to reach US$ 129,912.44 thousand by 2027.

    What is the CAGR for North America Non-Invasive Cardiac Output Monitoring Device Market by (2020 - 2027)?

    As per our report North America Non-Invasive Cardiac Output Monitoring Device Market, the market size is valued at US$ 95,471.09 thousand in 2020, projecting it to reach US$ 129,912.44 thousand by 2027. This translates to a CAGR of approximately 5.1% during the forecast period.

    What segments are covered in this report?

    The North America Non-Invasive Cardiac Output Monitoring Device Market report typically cover these key segments-

    • Device (Patches, Wristwatches, Probes & Catheters)
    • Indication (Hypertension, Coronary Diseases, Congenital Problems, Myocardial Ischemia and Infarction, Heart Failure, Arrhythmias)
    • End User (Hospitals, Emergency Services Centers, Homecare)

    What is the historic period, base year, and forecast period taken for North America Non-Invasive Cardiac Output Monitoring Device Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Non-Invasive Cardiac Output Monitoring Device Market report:

  • Historic Period : 2018-2019
  • Base Year : 2020
  • Forecast Period : 2021-2027
  • Who are the major players in North America Non-Invasive Cardiac Output Monitoring Device Market?

    The North America Non-Invasive Cardiac Output Monitoring Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • General Electric Company
  • Koninklijke Philips N.V.
  • Abbott
  • DELTEX MEDICAL
  • LiDCO
  • CONMED Corporation
  • ImaCor
  • NIMedical
  • Baxter International Inc.
  • Who should buy this report?

    The North America Non-Invasive Cardiac Output Monitoring Device Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Non-Invasive Cardiac Output Monitoring Device Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now